Vivimed Labs Share Price | Vivimed Labs Stock Screener
VIVIMEDLAB
Pharmaceuticals
Share Price NSE
₹7.63
▲
0.32 (4.38%)
Share Price BSE
₹5.78
▲
0.00 (0.00%)
As of April 15, 2026, the Vivimed Labs share price (NSE: VIVIMEDLAB) is ₹7.63 on NSE and ₹5.78 on BSE, up 4.38% from the previous close, with shares trading between ₹7.35 and ₹7.67, and a 52-week range of ₹5.28–₹26.60.
Analyse Vivimed Labs stock price data download and track historical price performance.
Use the Vivimed Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Vivimed Labs Market Cap
₹49.67 Cr.
VIVIMEDLAB P/E Ratio (TTM)
-1.38
Vivimed Labs P/B Ratio
-0.56
EPS (TTM)
₹-3.85
Dividend Yield
-
Debt to Equity
-
VIVIMEDLAB 52 Week High
₹26.60
Vivimed Labs 52 Week Low
₹5.28
Operating Margin
-68.00%
Profit Margin
-106.25%
VIVIMEDLAB Revenue (TTM)
₹16.00
EBITDA
₹-11.00
Net Income
₹-17.00
Total Assets
₹921.00
Total Equity
₹-35.00
Vivimed Labs Share Price Chart
Screen Vivimed Labs share price with an interactive chart. Analyse VIVIMEDLAB price trends and volatility across different timeframes.
Vivimed Labs Company Profile - Fundamental Screener
Screen Vivimed Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VIVIMEDLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE526G01021
Vivimed Labs Balance Sheet Screener
Screen VIVIMEDLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 921 | 951 | 995 | 1,266 | 1,289 | 2,210 | 2,329 | 2,394 | 2,062 | 2,044 |
| Current Assets | 328 | 343 | 339 | 507 | 529 | 975 | 1,231 | 1,282 | 1,094 | 1,133 |
| Fixed Assets | 408 | 418 | 436 | 520 | 502 | 1,045 | 965 | 1,035 | 879 | 814 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 548 | 546 | 532 | 528 | 517 | 605 | 496 | 365 | 510 | 561 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | -35 | -6 | 39 | 364 | 432 | 835 | 944 | 1,239 | 734 | 585 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 16 | 80 |
| Reserves & Surplus | -52 | -22 | 23 | 348 | 415 | 493 | 602 | 885 | 718 | 505 |
Vivimed Labs Income Statement Screener - Profit & Revenue Analysis
Screen Vivimed Labs income statement and profit fundamentals.
Analyze VIVIMEDLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vivimed Labs share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16 | 21 | 22 | 30 | 37 | 25 | 29 | 46 | 42 | 36 | 36 | 38 | 56 | 44 | 50 |
| Expenses | 27 | 22 | 22 | 28 | 36 | 25 | 40 | 67 | 40 | 40 | 36 | 201 | 61 | 54 | 59 |
| EBITDA | -11 | -1 | 0 | 2 | 1 | -1 | -11 | -21 | 1 | -4 | 0 | -164 | -5 | -9 | -9 |
| Operating Profit % | -68.00% | -5.00% | -1.00% | -10.00% | 3.00% | -3.00% | -37.00% | -74.00% | 3.00% | -18.00% | -1.00% | -444.00% | -9.00% | -21.00% | -17.00% |
| Depreciation | 5 | 5 | 5 | 6 | 7 | 4 | 4 | 6 | 5 | 5 | 5 | 96 | 4 | 4 | 4 |
| Interest | 1 | 2 | 1 | 2 | 1 | 0 | 0 | -33 | 13 | 12 | 11 | 9 | 9 | 9 | 9 |
| Profit Before Tax | -17 | -7 | -6 | -6 | -6 | -5 | -15 | 7 | -17 | -20 | -16 | -268 | -18 | -22 | -22 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | 0 | 0 | -2 | 0 | 0 | 0 |
| Net Profit | -17 | -7 | -6 | -6 | -6 | -5 | -15 | 5 | -16 | -20 | -16 | -266 | -18 | -22 | -22 |
| EPS | -2.00 | -0.88 | -0.66 | -0.68 | -0.72 | -0.62 | -1.84 | 0.63 | -1.94 | -2.40 | -1.88 | -32.08 | -2.20 | -2.66 | -2.68 |
Vivimed Labs Cash Flow Screener - Liquidity Fundamentals
Screen VIVIMEDLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -2 | -24 | 35 | 28 | 567 | 80 | 422 | 21 | 58 | 154 |
| Investing Activities | -5 | 28 | -5 | -16 | 404 | -196 | -89 | -164 | -69 | -190 |
| Financing Activities | 5 | -6 | -34 | -10 | -1,015 | 72 | -338 | 186 | 35 | 41 |
| Net Cash Flow | -1 | -2 | -3 | 1 | -44 | -44 | -5 | 44 | 25 | 4 |
Vivimed Labs Shareholding Pattern Screener
See Vivimed Labs shareholding pattern with promoter, FII, and DII holdings.
Check Vivimed Labs promoter holding and ownership changes for VIVIMEDLAB on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 7.57% | 20.94% | 7.77% | 7.77% | 7.77% | 20.94% | 20.94% | 20.94% |
| FII Holding | 1.64% | 1.64% | 1.64% | 1.64% | 1.64% | 1.64% | 1.64% | 1.64% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% | 0.12% |
| Public Holding | 68.75% | 57.91% | 65.19% | 65.18% | 65.06% | 57.24% | 57.23% | 57.23% |
| Other Holding | 21.91% | 19.39% | 25.29% | 25.30% | 25.41% | 20.07% | 20.07% | 20.07% |
| Shareholder Count | 47,492 | 48,957 | 48,928 | 48,925 | 49,221 | 49,016 | 49,012 | 49,003 |
Vivimed Labs Share Dividend Screener - Share Yield Analysis
Check Vivimed Labs dividend history with payout and yield data.
View Vivimed Labs dividend details including ex-dates and amounts for VIVIMEDLAB stock.
Vivimed Labs Stock Index Membership
See which indices include Vivimed Labs stock.
Check VIVIMEDLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vivimed Labs Market Events Screener - Corporate Actions
Get Vivimed Labs corporate actions including splits, bonuses, and buybacks.
Check Vivimed Labs stock events that may affect VIVIMEDLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.00% | ||
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 0.15% |
| 2026-03-13 | 2026-03-13 | Quarterly Result Announcement | NA | -24.97% |
| 2025-12-10 | 2025-12-10 | Extraordinary General Meeting | NA | 0.00% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.00% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-01-10 | 2025-01-10 | Quarterly Result Announcement | NA | 0.00% |
| 2025-01-03 | 2025-01-03 | Annual General Meeting | NA | 0.00% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 0.00% |
| 2024-08-14 | 2024-08-14 | Extraordinary General Meeting | NA | 0.00% |
| 2023-03-27 | 2023-03-27 | Annual General Meeting | NA | -26.11% |
| 2023-02-17 | 2023-02-17 | Annual General Meeting | NA | -13.09% |
Vivimed Labs Competitors Screener - Peer Comparison
Screen VIVIMEDLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,827 | 38.82 | 58,220 | 6.38% | 11,565 | 65.03 |
| Divis Laboratories | 174,081 | 69.38 | 10,560 | 8.73% | 2,520 | 43.32 |
| Torrent Pharmaceuticals | 157,634 | 71.51 | 13,886 | 20.34% | 2,138 | 66.05 |
| Cipla | 117,459 | 30.13 | 29,045 | 2.24% | 3,870 | 68.02 |
| Dr Reddys Laboratories | 114,822 | 27.10 | 33,593 | -0.44% | 3,998 | 73.77 |
| Zydus Life Science | 112,829 | 21.63 | 26,720 | 13.65% | 5,242 | 66.06 |
| Lupin | 110,115 | 20.00 | 27,488 | 19.98% | 5,345 | 66.98 |
| Mankind Pharma | 102,623 | 52.44 | 14,278 | 12.03% | 1,750 | 59.48 |
| Aurobindo Pharma | 89,879 | 25.78 | 33,385 | 3.21% | 3,376 | 65.10 |
| Laurus Labs | 80,995 | 88.02 | 6,868 | 22.01% | 890 | 70.64 |
Vivimed Labs Company Announcements - News Screener
Screen VIVIMEDLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-17 | Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP) | - |
| 2026-05-30 | Board Meeting Postponed | - |
| 2026-05-26 | Update on board meeting | - |
| 2026-05-19 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-17 | Board Meeting Intimation for Audited Results | - |
| 2026-04-23 | Corporate Insolvency Resolution Process (CIRP)-Public Announcement | - |
| 2026-04-17 | Admission To CIRP | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-06 | Initial Disclosure | - |
| 2026-04-02 | Closure of Trading Window | - |
| 2026-03-13 | Q3 FY 2026 RESULTS | - |
| 2026-03-09 | Board Meeting Intimation for Notice Of Board Meeting | - |
| 2026-02-16 | Updates | - |
| 2026-02-13 | Application For PPIRP | - |
| 2026-02-11 | Cancellation of Board Meeting | - |
| 2026-02-09 | Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | - |
| 2026-02-03 | Updates | - |
| 2026-02-02 | Board Meeting Intimation for 31St December 2025 Results | - |
| 2026-01-13 | Intimation | - |